-+ 0.00%
-+ 0.00%
-+ 0.00%

Opaleye Management reports $16,404 Grace Therapeutics common share purchase

PUBT·10/01/2026 20:33:18
Opaleye Management reports $16,404 Grace Therapeutics common share purchase
  • Opaleye Management, a 10% owner of Grace Therapeutics, reported buying 7,849 common shares at $2.09.
  • Indirect stake held through Opaleye, L.P. rose to 2,798,167 shares.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Grace Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-045358), on October 01, 2026, and is solely responsible for the information contained therein.